Journal of Biological Chemistry · 2006 · 86 citations · 13 references
MedicineMolecular BiologyOncologyCell SignalingGene ExpressionSignal TransductionBone FormationBone ResorptionCancer Cell SignalingOsteoclast BiologyOsteoclast FunctionOsteogenesisBone Resorption InhibitionColony-stimulating Factor 1 SignalingNf-κb SignalingOsteoclast Precursor CellsOsteoclast PrecursorsOsteoclast RegulationPre-osteoclast DifferentiationRankl-mediated Osteoclastogenesis
Osteoclasts differentiate from hematopoietic mononuclear precursor cells under the control of both colony stimulating factor-1 (CSF-1, or M-CSF) and receptor activator of NF-kappaB ligand (RANKL, or TRANCE, TNFSF11) to carry out bone resorption. Using high density gene microarrays, we followed gene expression changes in long bone RNA when CSF-1 injections were used to restore osteoclast populations in the CSF-1-null toothless (csf1(tl)/csf1(tl)) osteopetrotic rat. We found that ovarian cancer G-protein-coupled receptor 1 (OGR1, or GPR68) was strongly up-regulated, rising >6-fold in vivo after 2 days of CSF-1 treatments. OGR1 is a dual membrane receptor for both protons (extracellular pH) and lysolipids. Strong induction of OGR1 mRNA was also observed by microarray, real-time RT-PCR, and immunoblotting when mouse bone marrow mononuclear cells and RAW 264.7 pre-osteoclast-like cells were treated with RANKL to induce osteoclast differentiation. Anti-OGR1 immunofluorescence showed intense labeling of RANKL-treated RAW cells. The time course of OGR1 mRNA expression suggests that OGR1 induction is early but not immediate, peaking 2 days after inducing osteoclast differentiation both in vivo and in vitro. Specific inhibition of OGR1 by anti-OGR1 antibody and by small inhibitory RNA inhibited RANKL-induced differentiation of both mouse bone marrow mononuclear cells and RAW cells in vitro, as evidenced by a decrease in tartrate-resistant acid phosphatase-positive osteoclasts. Taken together, these data indicate that OGR1 is expressed early during osteoclastogenesis both in vivo and in vitro and plays a role in osteoclast differentiation.
13
Proton-sensing G-protein-coupled receptors
Marie‐Gabrielle Ludwig, M. Vanek, Danilo Guerini et al. · Nature · 2003 · 742 citations
Removal of Osteoclast Bone Resorption Products by Transcytosis
Jari Salo, Petri Lehenkari, Mika Mulari et al. · Science · 1997 · 433 citations
Medicine, Biochemistry, Cell Biology +16
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Yan Xu, Kui Zhu, Guiying Hong et al. · Nature Cell Biology · 2000 · 290 citations
Svetlana V. Komarova, Alexey Pereverzev, Jonathan Shum et al. · Proceedings of the National Academy of Sciences · 2005 · 159 citations · Full text